Alex Kim
Director/Miembro de la Junta en Co-D Therapeutics, Inc. .
Relaciones activas
| Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
|---|---|---|---|---|
| Abdalla A. Saad | M | - |
Co-D Therapeutics, Inc.
 Co-D Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Co-D Therapeutics, Inc. operates as a preclinical stage biopharmaceutical firm. Its product, Triolimus, helps treats cancer. The company was founded by Kevin R. Kozak, Glen S. Kwon, and Abdalla A. Saad and is headquartered in Madison, WI. | - |
| Kevin R. Kozak | M | - |
Co-D Therapeutics, Inc.
Co-D Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Co-D Therapeutics, Inc. operates as a preclinical stage biopharmaceutical firm. Its product, Triolimus, helps treats cancer. The company was founded by Kevin R. Kozak, Glen S. Kwon, and Abdalla A. Saad and is headquartered in Madison, WI. | - |
| Yang-Gon Jin | M | 58 |
Elevar Therapeutics, Inc.
 Elevar Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Elevar Therapeutics, Inc. engages in the provision of biopharmaceutical services. It offers Rivoceranib, a small-molecule angiogenesis inhibitor in gastric cancer that use in the growth and proliferation in cancer cells. The company was founded by Sung Chul Kim and Soo Whan Choi in 2005 and is headquartered in Salt Lake City, UT. | 4 años |
| Glen S. Kwon | M | - |
Co-D Therapeutics, Inc.
Co-D Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Co-D Therapeutics, Inc. operates as a preclinical stage biopharmaceutical firm. Its product, Triolimus, helps treats cancer. The company was founded by Kevin R. Kozak, Glen S. Kwon, and Abdalla A. Saad and is headquartered in Madison, WI. | - |
| Paul V. Radspinner | M | - |
Co-D Therapeutics, Inc.
Co-D Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Co-D Therapeutics, Inc. operates as a preclinical stage biopharmaceutical firm. Its product, Triolimus, helps treats cancer. The company was founded by Kevin R. Kozak, Glen S. Kwon, and Abdalla A. Saad and is headquartered in Madison, WI. | - |
| J. Patrick Genn | M | - |
Co-D Therapeutics, Inc.
Co-D Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Co-D Therapeutics, Inc. operates as a preclinical stage biopharmaceutical firm. Its product, Triolimus, helps treats cancer. The company was founded by Kevin R. Kozak, Glen S. Kwon, and Abdalla A. Saad and is headquartered in Madison, WI. | - |
| Gun Kim Dong | M | - |
Elevar Therapeutics, Inc.
Elevar Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Elevar Therapeutics, Inc. engages in the provision of biopharmaceutical services. It offers Rivoceranib, a small-molecule angiogenesis inhibitor in gastric cancer that use in the growth and proliferation in cancer cells. The company was founded by Sung Chul Kim and Soo Whan Choi in 2005 and is headquartered in Salt Lake City, UT. | 4 años |
Gráfico relacional
Relaciones con varias empresas
Antiguas relaciones
| Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
|---|---|---|---|---|
| Kate McKinley | F | 47 |
Elevar Therapeutics, Inc.
Elevar Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Elevar Therapeutics, Inc. engages in the provision of biopharmaceutical services. It offers Rivoceranib, a small-molecule angiogenesis inhibitor in gastric cancer that use in the growth and proliferation in cancer cells. The company was founded by Sung Chul Kim and Soo Whan Choi in 2005 and is headquartered in Salt Lake City, UT. | 3 años |
| Anton G. Gueth | M | 67 |
Elevar Therapeutics, Inc.
Elevar Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Elevar Therapeutics, Inc. engages in the provision of biopharmaceutical services. It offers Rivoceranib, a small-molecule angiogenesis inhibitor in gastric cancer that use in the growth and proliferation in cancer cells. The company was founded by Sung Chul Kim and Soo Whan Choi in 2005 and is headquartered in Salt Lake City, UT. | - |
| Mark Gelder | M | 67 |
Elevar Therapeutics, Inc.
Elevar Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Elevar Therapeutics, Inc. engages in the provision of biopharmaceutical services. It offers Rivoceranib, a small-molecule angiogenesis inhibitor in gastric cancer that use in the growth and proliferation in cancer cells. The company was founded by Sung Chul Kim and Soo Whan Choi in 2005 and is headquartered in Salt Lake City, UT. | 1 años |
| Swati Kumar | F | - |
Elevar Therapeutics, Inc.
Elevar Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Elevar Therapeutics, Inc. engages in the provision of biopharmaceutical services. It offers Rivoceranib, a small-molecule angiogenesis inhibitor in gastric cancer that use in the growth and proliferation in cancer cells. The company was founded by Sung Chul Kim and Soo Whan Choi in 2005 and is headquartered in Salt Lake City, UT. | - |
| Guoqing Chen | M | - |
Elevar Therapeutics, Inc.
Elevar Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Elevar Therapeutics, Inc. engages in the provision of biopharmaceutical services. It offers Rivoceranib, a small-molecule angiogenesis inhibitor in gastric cancer that use in the growth and proliferation in cancer cells. The company was founded by Sung Chul Kim and Soo Whan Choi in 2005 and is headquartered in Salt Lake City, UT. | - |
| Arlo McGinn | M | - |
Elevar Therapeutics, Inc.
Elevar Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Elevar Therapeutics, Inc. engages in the provision of biopharmaceutical services. It offers Rivoceranib, a small-molecule angiogenesis inhibitor in gastric cancer that use in the growth and proliferation in cancer cells. The company was founded by Sung Chul Kim and Soo Whan Choi in 2005 and is headquartered in Salt Lake City, UT. | - |
| Wook Kim | M | 55 |
Elevar Therapeutics, Inc.
Elevar Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Elevar Therapeutics, Inc. engages in the provision of biopharmaceutical services. It offers Rivoceranib, a small-molecule angiogenesis inhibitor in gastric cancer that use in the growth and proliferation in cancer cells. The company was founded by Sung Chul Kim and Soo Whan Choi in 2005 and is headquartered in Salt Lake City, UT. | - |
Estadísticas
| País | Relaciones | % del total |
|---|---|---|
| Estados Unidos | 14 | 100.00% |
Antigüedad de la relación
Activas
Pasados
Hombre
Mujer
Administradores
Ejecutivos
Origen de las relaciones
- Bolsa de valores
- Insiders
- Alex Kim
- Red Personal
